Aromatase inhibitors for breast cancer: Advantages over tamoxifen in early-stage disease
Patients survive longer, recurrences occur later, and certain side effects occur less often. Overall, the evidence for late-stage disease is much poorer.
from Top Health News – ScienceDaily http://ift.tt/2imfmQI
from Tumblr http://ift.tt/2hRpbCJ
No comments:
Post a Comment